These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7514311)

  • 21. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on quality of China made NS3 antigen].
    Yang Z; Qi Z; Zhang Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):253-7. PubMed ID: 12526329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic tests for hepatitis C.
    Gretch DR
    Hepatology; 1997 Sep; 26(3 Suppl 1):43S-47S. PubMed ID: 9305663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of the new Architect HCV Ag® assay in the management of hepatitis C naïve patients].
    Alados-Arboledas JC; López-Prieto MD; López-Cepero J
    Enferm Infecc Microbiol Clin; 2013 May; 31(5):351-2. PubMed ID: 23182239
    [No Abstract]   [Full Text] [Related]  

  • 28. Serological and molecular biology screening techniques for HVC infection.
    De Lamballerie X
    Nephrol Dial Transplant; 1996; 11 Suppl 4():9-11. PubMed ID: 8918743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of HCV genotypes on seroreactivity against HCV antigens immobilized on the RIBA 3.0 SIA.
    Jain N; Quan S; Polito A; Lau JY
    J Hepatol; 1999 Jan; 30(1):173. PubMed ID: 9927167
    [No Abstract]   [Full Text] [Related]  

  • 30. Serological responses to infection with three different types of hepatitis C virus.
    Chan SW; Simmonds P; McOmish F; Yap PL; Mitchell R; Dow B; Follett E
    Lancet; 1991 Nov; 338(8779):1391. PubMed ID: 1682751
    [No Abstract]   [Full Text] [Related]  

  • 31. Nanotechnology: A reality for diagnosis of HCV infectious disease.
    Arca-Lafuente S; Martínez-Román P; Mate-Cano I; Madrid R; Briz V
    J Infect; 2020 Jan; 80(1):8-15. PubMed ID: 31580870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of HCV diversity on diagnosis tools for HCV infection.
    Mavromara P; Sall A; Kalinina O; Horm V; Budkowska A;
    Med Mal Infect; 2005 Jun; 35 Suppl 2():S103-4. PubMed ID: 15978361
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies to a novel antigen in acute hepatitis C virus infections.
    Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
    Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of hepatitis C virus infection].
    Muñoz Espinosa LE
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S29-35. PubMed ID: 12712850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The evolution of serologic tests in the diagnosis of HCV infections].
    Mancini C; Filadoro F
    Recenti Prog Med; 1994 Jan; 85(1):64-71. PubMed ID: 7514311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cDNA cloning of c33-c antigen gene derived from NS3 region of Chinese HCV genome, expression in Escherichia coli and development of HCV EIA second-generation diagnostic kit.
    Yang YP; Liu CB; Jin DY; Zhan MY; Tang Q; Xia NS; Cao JY; Li JY
    Sci China B; 1994 Feb; 37(2):190-202. PubMed ID: 7520701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic heterogeneity of the NS3 proteins in hepatitis C virus genotypes 1 and 6.
    Qiao W; Xie P; Cai B; Li L
    Intervirology; 2011 Feb; 54(2):53-60. PubMed ID: 20829600
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.